Influence of Obesity, Weight Loss, and Free Fatty Acids on Skeletal Muscle Clock Gene Expression.
The molecular circadian clock plays a role in metabolic homeostasis. We tested the hypothesis obesity and systemic factors associated with insulin resistance affect skeletal muscle clock gene expression. We determined clock gene expression in skeletal muscle of obese women (n=5) and men (n=18) before and 6 months after Roux-en-Y gastric bypass (RYGB) surgery and normal weight controls (women n=6, men n=8). Skeletal muscle clock gene expression was affected by obesity and weight loss. CRY1 mRNA (P=0.05) was increased and DBP mRNA (P<0.05) was decreased in obese versus normal weight women and restored to control levels after RYGB-induced weight loss. CLOCK, CRY1, CRY2 and DBP mRNA (P<0.05) was decreased in obese men as compared to normal weight men. Expression of all other clock genes was unaltered by obesity or weight loss in both cohorts. We correlated clock gene expression with clinical characteristics of the participants. Among the genes studied, DBP and PER3 expression was inversely correlated with plasma lipids in both cohorts. Circadian time-course studies revealed that core clock genes oscillate over time (P<0.05), with BMAL1, CIART, CRY2, DBP, PER1 and PER3 expression profiles altered by palmitate treatment. In conclusion, skeletal muscle clock gene expression and function is altered by obesity, coincident with changes in plasma lipid levels. Palmitate exposure disrupts clock gene expression in myotubes, indicating dyslipidemia directly alters the circadian program. Strategies to reduce lipid overload and prevent elevations in NEFA and cholesterol levels may sustain circadian clock signals in skeletal muscle.